Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Interest & Investment Income (2023 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Interest & Investment Income for 3 consecutive years, with -$515000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest & Investment Income fell 156.22% to -$515000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $137000.0, a 96.35% decrease, with the full-year FY2024 number at $3.4 million, down 12.81% from a year prior.
  • Interest & Investment Income was -$515000.0 for Q3 2025 at Orchestra BioMed Holdings, down from -$36000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.0 million in Q1 2024 to a low of -$515000.0 in Q3 2025.
  • A 3-year average of $485750.0 and a median of $712000.0 in 2024 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: rose 0.11% in 2024, then crashed 156.22% in 2025.
  • Orchestra BioMed Holdings' Interest & Investment Income stood at $915000.0 in 2023, then plummeted by 42.95% to $522000.0 in 2024, then tumbled by 198.66% to -$515000.0 in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Interest & Investment Income are -$515000.0 (Q3 2025), -$36000.0 (Q2 2025), and $166000.0 (Q1 2025).